Gladstone NOW: The Campaign Join Us on the Journey✕
On November 6, 2019, Gordon Keller, PhD, was presented with the 2019 Ogawa-Yamanaka Stem Cell Prize. A world-renowned stem cell scientist, Keller was selected for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from the late Hiro and Betty Ogawa and is supported by the Gladstone Institutes. It also recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka.
In 2019, Gladstone formed a partnership with the Cell Press group to support this important prize.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
Ogawa Stem Cell Prize Stem Cells/iPSCs Regenerative Medicine News Release AwardsBruneau, director of the Gladstone Institute of Cardiovascular Disease, will receive the association’s highest scientific honor in November.
News Release Congenital Heart Disease Cardiovascular Disease AwardsGladstone is one of only 12 institutions nationwide to receive the award for its postdoctoral programs.
News Release Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Postdoc Advisory Committee Awards